Indian CROs Move Up R&D Value Chain From Outsourcing Services To Partnering With MNCs
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - India, along with China, is increasingly becoming a popular destination for pharmaceutical research and development outsourced from the West, and more multinational companies are partnering with Indian CROs to improve productivity, cut costs and bring more drugs to market faster
You may also be interested in...
India’s Expanding Middle Class To Drive Pharma Industry Annual Growth to 20 Percent By 2015
NEW DELHI - India's pharmaceutical industry is forecast to grow by nearly 20 percent annually by 2015, spurred by rising incomes and better health awareness, according to a study commissioned by Indian industry lobby group the Confederation of Indian Industry
India’s Expanding Middle Class To Drive Pharma Industry Annual Growth to 20 Percent By 2015
NEW DELHI - India's pharmaceutical industry is forecast to grow by nearly 20 percent annually by 2015, spurred by rising incomes and better health awareness, according to a study commissioned by Indian industry lobby group the Confederation of Indian Industry
A Tale Of Two Giants; Tracking India And China’s Rise In The Pharmaceutical Market
SHANGHAI - The nature of business relationships between multinational pharma companies and Indian and Chinese firms varies significantly, according to a recent study released by the Ewing Marion Kauffman Foundation